Abstract:PURPOSE:To investigate the use of stiffness value and stiffness ratio (ratio of lesion to background liver parenchyma values) to discriminate malignant from benign focal liver lesions by using histologic results as the reference standard.MATERIALS AND METHODS:This study was approved by the institutional review board, and written informed consent was obtained. Three hundred seventy-three patients with focal liver lesions proven at histologic examination underwent measurement of liver stiffness with elastography point quantification. First, stiffness values in two regions of the background liver parenchyma (at 0.5-2 cm and >2 cm from the lesion periphery) near 163 hepatocellular carcinomas were analyzed to determine a reference background liver for calculating the stiffness ratio. Second, the use of the lesion stiffness value and the stiffness ratio for prediction of liver malignancy was investigated in a cohort of patients with 58 benign and 201 malignant lesions. Results were validated in another independent cohort of patients with 25 benign and 89 malignant lesions by using analysis of the area under the receiver operating characteristic (AUC) curve.RESULTS:The coefficient of variation for the background liver at 0.5-2 cm from the lesion was higher (196%) than that at greater than 2 cm from the lesion (66%). In the development phase, diagnostic accuracy with use of the stiffness value was significantly higher than that with use of the stiffness ratio for discrimination of malignant from benign lesions (AUC, 0.86 vs 0.66, respectively; P < .001). Diagnostic performance with the stiffness value was lower than that with the stiffness ratio (AUC, 0.53 vs 0.86, respectively; P < .001) for discrimination of cirrhotic nodules from other benign lesions. Diagnostic performance with the stiffness value was significantly lower than that with the stiffness ratio (AUC, 0.58 vs 0.71 respectively; P = .007) for discrimination of metastasis from primary liver cancers. In the validation phase, similar findings were revealed for the discrimination of malignant from benign lesions (AUC, 0.87 vs 0.67; P < .001) and discrimination between metastasis and primary liver cancers (AUC, 0.49 vs 0.73; P < .001).CONCLUSION:Use of stiffness values measured in the liver parenchyma at more than 2 cm from the lesion allowed better diagnostic performance than did values measured in a region closer to the tumor. Stiffness value was more accurate than stiffness ratio for differentiation of malignant from benign focal liver lesions, but the stiffness ratio might be useful for subclassification of benign and malignant lesions. Online supplemental material is available for this article.

Acoustic Radiation Force Impulse Imaging in Space-occupying Liver Lesions: Correlation with Pathology

[Liver Stiffness Measured by Acoustic Radiation Force Impulse Imaging in Assessing Hepatic Functional Reserve in Patients with Space-Occupying Lesions in the Liver].

Comparative study on clinical and pathological changes of liver fibrosis with acoustic radiation force impulse elastography imaging

Quantitative Assessment of Ischemic Liver's Elastic Changes in Rabbits Using Acoustic Radiation Force Impulse (ARFI)

Non-invasive Assessment of Liver Fibrosis in Patients with Alcoholic Liver Disease Using Acoustic Radiation Force Impulse Elastography.

Preliminary Results of Acoustic Radiation Force Impulse Technique in the Prediction of Chronic Liver Fibrosis

Evaluation of liver fibrosis in a rat model by acoustic radiation force impulse elastography

Evaluation of Liver Fibrosis and Portal Hypertension in Chronic Hepatitis B Patients by Acoustic Radiation Force Impulse Elastography

Acoustic Radiation Force Impulse Imaging for Assessing Liver Fibrosis Preoperatively in Infants With Biliary Atresia: Comparison With Liver Fibrosis Biopsy Pathology.

Liver and spleen stiffness measured by acoustic radiation force impulse elastography for noninvasive assessment of liver fibrosis and esophageal varices in patients with chronic hepatitis B.

Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis?

Longitudinal Monitoring of Liver Stiffness by Acoustic Radiation Force Impulse Imaging in Patients with Chronic Hepatitis B Receiving Entecavir.

Correlativity Analysis between Liver Shear Wave Speed and Fibrosis Grades in Chronic Hepatic Diseases

Diagnostic value of acoustic radiation force impulse in patients with non- alcoholic simple fatty liver

Preliminary Application of Acoustic Radiation Force Impulse Imaging in Radiofrequency Ablation of Hepatic Malignancies

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

Noninvasive assessment of liver viscoelasticity by acoustic radiation force with a rat model

Hepatocellular Carcinoma: Stiffness Value and Ratio to Discriminate Malignant from Benign Focal Liver Lesions.

[Diagnostic Value of Liver Stiffness Measurement for the Evaluation of Liver Fibrosis in Nonalcoholic Fatty Liver].

Clinical Study on the Liver Stiffness Value Measured by FibroScan and Aspartate Transaminase-to-platelet Ratio Index for Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis B

Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD